Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer, urothelial cancer and genitourinary cancer clinical trials and studies.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Clinical Trials and Studies

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)
Primary care physician use of patient race and polygenic risk scores in medical decision-making
Recurrence Rates for Pediatric Benign Ovarian Neoplasms

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Current Clinical Trials and Studies

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Related Stories

Stomach cancer signs and symptoms everyone should know

Screening for lung cancer: Questions and answers

Lung cancer patient finds hope after second opinion

‘When they saved my life, they saved Christmas’

Schedule an Appointment